The global mental health therapeutics landscape in 2026 is experiencing a complex and contested evolution in the role of benzodiazepine medications within anxiety disorder management, with the Alprazolam Market reflecting the tension between persistent clinical demand for rapid-acting anxiolytic therapy and growing psychiatric professional society guidance recommending more cautious...